Alchemy 21/12 research desk

Emerging Science

The papers changing how we think about what skin can absorb, how the barrier behaves and what regenerative actives can realistically do.

Alchemy 21/12 did not conduct or sponsor these studies unless specifically stated. Research abstracts are original editorial summaries. Our position explains how we interpret the evidence and does not imply that the authors studied or endorsed Alchemy 21/12 formulas.

PDRN • Topical delivery

Topical medium-length PDRN enhances dermal extracellular matrix repair in photodamaged skin

PLOS One July 10, 2026

Mechanistic • Ex vivo • Human

Research abstract

Researchers evaluated a medium-length PDRN preparation with an average molecular weight no greater than 850 kDa across fibroblast signaling, reconstructed epidermis, porcine skin, UV-damaged human skin and a 31-person randomized split-face clinical study. At 0.1%, PDRN-associated signals appeared in viable epidermal regions, while the clinical formula improved measured periocular wrinkles, dermal thickness, density and firmness over 28 days.

The study connected these results to PI3K-Akt, TGF-β/Smad and autophagy-related signaling. Important limitations include a one-person in-vivo penetration pilot, the inability of Raman spectroscopy to identify applied PDRN with complete certainty and a clinical period too short to separate mature remodeling from hydration-related effects.

Our position

This is the strongest integrated evidence currently available for topically applied PDRN. It materially strengthens the case that a defined medium-length PDRN can move beyond the surface and influence viable skin. It does not prove that every PDRN source or finished formula behaves the same way.

Formula relevance

Crystal PDRN Glass Serum • CORRECTV Complex

The clinical concentration was 1,000 ppm, matching CORRECTV. Crystal contains 600 ppm of vegan PDRN with a documented lower-molecular-weight distribution. That creates a credible basis for meaningful activity at the lower concentration, although equivalent clinical performance must still be demonstrated with finished-product testing.

Read the paper

PDRN • Molecular conformation

Mechanical stress-driven conformational compaction of polydeoxyribonucleotide for enhanced transdermal regenerative therapy

Biomaterials Science July 28, 2026

Materials science • Clinical signal

Research abstract

This study used mild vacuum to move PDRN through silica-particle media, reducing its radius of gyration from 52.92 to 29.36 nanometers without detectable fragmentation or loss of biological activity. The compacted material showed improved cellular uptake, procollagen production, penetration and wound-repair activity while preserving adenosine A2A receptor signaling.

Our position

The paper changes the delivery discussion by showing that molecular weight is not the only physical variable. Three-dimensional conformation may also affect how a large biomolecule moves through skin. The process is proprietary-style manufacturing evidence, not proof that ordinary mixing or shaking compacts PDRN.

Formula relevance

Crystal PDRN Glass Serum • CORRECTV Complex

This creates a useful future supplier and processing question: can conformational state be characterized and maintained in a finished serum? Until that is tested, Alchemy treats this as a promising delivery strategy rather than a claim about the PDRN currently in our formulas.

Read the paper

Peptides • Delivery architecture

Interface-engineered supramolecular collagen peptide nanocapsules for barrier repair and matrix remodeling

Journal of Controlled Release July 21, 2026

Delivery • Mechanistic • Human

Research abstract

A non-covalent carrier assembled from α-bisabolol and dipalmitoyl hydroxyproline increased viable-epidermal deposition of a roughly 5 kDa recombinant collagen peptide by 22.43-fold compared with the free peptide. The reported penetration depth reached approximately 40 micrometers after eight hours. The system also affected filaggrin, loricrin, inflammatory markers and multiple collagen types.

Our position

The important idea is not that a collagen peptide proves EGF penetration. It is that a biologically active carrier can protect a hydrophilic macromolecule, improve deposition and contribute useful activity of its own. Delivery remains specific to the molecule, carrier and finished vehicle.

Formula relevance

Future regenerative delivery research

The payload occupies the same broad size neighborhood as certain signaling proteins used in cosmetic research. This supports Alchemy's ongoing evaluation of active, non-covalent carrier systems for future formulations rather than assuming naked macromolecules will cross intact stratum corneum efficiently.

Read the paper

Polynucleotides • Inflammatory signaling

Polynucleotides attenuate atopic-dermatitis-like inflammatory signaling in keratinocytes and macrophages

Biomedicines August 13, 2026

In vitro

Research abstract

Trout-derived polynucleotides reduced activation of NF-κB, MAPK and JAK1/STAT3 pathways in stimulated keratinocytes and macrophages. Treatment also lowered multiple inflammatory cytokines and chemokines, including IL-6, IL-1β, TSLP, CCL17 and CCL22. Functional testing used concentrations of 100 to 500 micrograms per milliliter.

Our position

This is credible evidence of direct cellular activity once polynucleotides reach responsive cells. It is not evidence of penetration through intact human skin and does not support claims to treat eczema or atopic dermatitis.

Formula relevance

Crystal PDRN Glass Serum • CORRECTV Complex

Crystal's 600 ppm sits close to the tested functional range. CORRECTV's 1,000 ppm is above it, but the study did not functionally test that concentration. The paper supports an inflammation-modulating rationale while reinforcing the need to evaluate the actual finished formulas.

Read the paper

Growth factors • Compromised skin

Topical recombinant human EGF gel plus urea ointment in capecitabine-induced hand-foot syndrome

Journal of Oncology Pharmacy Practice August 31, 2026

Retrospective human case series

Research abstract

In an 83-patient retrospective series involving grade II or III chemotherapy-related hand-foot syndrome, 80.7% of patients improved by at least one severity grade after three weeks of topical recombinant human EGF gel plus urea ointment. Median time to documented improvement was 10 days, and no serious treatment-related adverse events were reported.

Our position

This provides a useful human signal for topical rhEGF on severely compromised skin, but the uncontrolled design cannot separate the effects of EGF, urea, supportive care or treatment timing. Medical wound-adjacent evidence also cannot be transferred directly to intact cosmetic-use facial skin.

Formula relevance

Future regenerative delivery research

The study offers biological reassurance that recombinant growth factors and urea can be used within the same treatment regimen. Because they were separate combined interventions, it does not establish storage stability inside a single formula or prove delivery from any future cosmetic system.

Read the paper

Skin barrier • Cleansing behavior

Cool versus warm water for facial cleansing

International Journal of Cosmetic Science September 10, 2026

Randomized controlled study

Research abstract

Fifty-two adults completed a randomized 10-day cleansing study comparing cool and warm water. Repeated warm-water cleansing increased transepidermal water loss by approximately 3.4 g/m²/h, while the smaller change with cool water was not statistically significant. Cool water also reduced surface pH by 0.4 units, and makeup-removal performance did not differ between temperatures.

Our position

The study supports a simple barrier-preserving behavior without requiring consumers to sacrifice cleansing performance. Its short duration, use of a single cleansing balm and manufacturer funding limit how broadly the result should be generalized.

Formula relevance

Barrier Cleanser • The Alchemy Method

Cool-to-lukewarm water is now a defensible usage recommendation within Alchemy's barrier-first method. The finding supports the cleansing ritual, but it is not a direct clinical test of the Alchemy Barrier Cleanser.

Read the paper